Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Charlottesville, VA
SEC filing record 1 source field available
Fiscal year end
31 December
ADIAL PHARMACEUTICALS, INC. has filed 544 SEC EDGAR filings since 16 Mar 2011

SEC filing history

Showing 101-125 of 544 matching filings.

Per page
25
Current page
5
8-K File 001-38323

CURRENT REPORT

Filing date
18 Dec 2024
Reporting date
13 Dec 2024
Next action
Verify source filing
S-8 File 333-283756

REGISTRATION STATEMENT

Filing date
12 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
06 Dec 2024
Reporting date
05 Dec 2024
Next action
Verify source filing
4

4 filing

Filing date
05 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
18 Nov 2024
Reporting date
14 Nov 2024
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Nov 2024
Reporting date
16 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Nov 2024
Reporting date
16 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90718

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
13 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
12 Nov 2024
Reporting date
12 Nov 2024
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
Next action
Verify source filing
ARS File 001-38323

FORM ARS

Filing date
30 Sep 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38323

PROXY STATEMENT

Filing date
27 Sep 2024
Reporting date
12 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
13 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
14 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
26 Apr 2024
Reporting date
24 Apr 2024
Next action
Verify source filing
424B3 File 333-278652

PROSPECTUS

Filing date
23 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278652

EFFECT filing

Filing date
19 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-276496

PROSPECTUS SUPPLEMENT

Filing date
18 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
18 Apr 2024
Reporting date
18 Apr 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-278652

UPLOAD filing

Filing date
17 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
16 Apr 2024
Reporting date
10 Apr 2024
Next action
Verify source filing
S-3 File 333-278652

REGISTRATION STATEMENT

Filing date
12 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38323

ANNUAL REPORT

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .